(Q42694650)

English

Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study

scientific article published on 17 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Gregers G Hermann

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Karin Mogensen

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Steen Carlsson

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Niels Marcussen

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Susanne Duun

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

17 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

8 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

E297-303

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A second-look TUR in T1 transitional cell carcinoma: why?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10090.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10090.X

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42694650&oldid=1965654271"